Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IMS Health was the global leader in healthcare data analytics and information services for pharmaceutical and life sciences companies. It did not develop drugs but provided critical market intelligence and real-world evidence solutions to support clinical development, commercialization strategies, and regulatory compliance for clients across pharma, biotech, medical devices, generics, and consumer health sectors. In October 2016 it merged with Quintiles to form QuintilesIMS—now known as IQVIA—creating one of the world’s largest integrated providers of advanced analytics, technology solutions and clinical research services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IMS Health.